Buscar resultados de ensayos clínicos
Neuroblastoma - 49 Studies Found
| Estado | Estudiar |
| Recruiting |
Nombre del estudio: Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Condición:
Fecha: 2013-01-09 Intervenciones:
|
| Not yet recruiting |
Nombre del estudio: Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma Condición:
Intervenciones: |
| Recruiting |
Nombre del estudio: Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 Condición:
Fecha: 2014-12-04 Intervenciones:
|
| Recruiting |
Nombre del estudio: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Condición:
Intervenciones: |
| Recruiting |
Nombre del estudio: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Condición:
Intervenciones: |
| Completed |
Nombre del estudio: Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin Condición:
Intervenciones: |
| Completed |
Nombre del estudio: Neuroblastoma Precision Trial Condición: Neuroblastoma Fecha: 2016-06-03 Intervenciones: Other: Gene panel sequencing of tumor specimens Archival or biopsied tumor specimens will undergo gene p |
| Terminated |
Nombre del estudio: Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma Condición: Neuroblastoma Fecha: 2008-12-11 Intervenciones:
|
| Completed |
Nombre del estudio: Therapy for Children With Advanced Stage High Risk Neuroblastoma Condición: Neuroblastoma Fecha: 2005-09-12 Intervenciones:
|
| Completed |
Nombre del estudio: Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma Condición: Neuroblastoma Fecha: 2011-12-15 Intervenciones:
|